{
"@context": "https://schema.org",
"@type": "Article",
"headline": "FCA Issues to Watch: Pharmaceutical and Device Developments",
"url": "https://www.lexblog.com/2017/05/15/fca-issues-to-watch-pharmaceutical-and-device-developments/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-6SCXNRD6",
"url": "https://www.lexblog.com/lib/6SCXNRD6/"
},
"datePublished": "2017-05-15T15:40:17-04:00",
"dateModified": "2022-08-17T08:26:48-04:00",
"author": {
"@type": "Person",
"name": "Bass, Berry & Sims"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Bass, Berry & Sims PLC"
},
"organizationScope": "at-publication",
"isPartOf": "Inside the False Claims Act",
"about": "Criminal ยท Health Care and Life Sciences",
"sourceUrl": "http://www.insidethefca.com/?p=2007",
"sourceStability": "may-move"
}